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STUDY QUESTION: Can we identify patient characteristics that distinguish which ovulatory infertile women undergoing hysterosalpingog-
raphy (HSG) benefit more or less from flushing with oil-based contrast medium compared to water-based contrast medium?
SUMMARY ANSWER: In ovulatory infertile women, HSG with oil-based contrast medium resulted in higher 6-month ongoing pregnancy
and live birth rates as compared to HSG with water-based contrast medium and this treatment effect was independent of characteristics of
the couple.
WHAT IS KNOWN ALREADY: We recently showed that in infertile women undergoing HSG, flushing with oil-based contrast medium
resulted in more ongoing pregnancies than flushing with water-based contrast medium.
STUDY DESIGN, SIZE, DURATION: We used data from our randomized clinical trial (RCT) in which 1,119 ovulatory infertile women
undergoing HSG during fertility work-up were randomized for use of oil-based (N = 557) or water-based (N = 562) contrast medium.
PARTICIPANTS/MATERIALS, SETTING, METHODS: We built logistic regression models to predict ongoing pregnancy and live birth
(secondary outcome) as a function of the specific contrast, the specific marker, and marker-by-contrast-interaction. Markers considered were
female age, maternal ethnicity, female smoking, body mass index (BMI), duration of infertility, infertility being primary or secondary, sperm
quality, and previous appendectomy.
MAIN RESULTS AND THE ROLE OF CHANCE: The 6-month ongoing pregnancy rates in the overall population were 39.7% after
use of oil-based contrast versus 29.1% after use of water-based contrast medium [relative risk (RR), 1.37; 95% confidence interval (CI),
1.16–1.61; P < 0.001]. Among the studied baseline characteristics, BMI (P = 0.002) and semen volume (P = 0.02) were statistically significant
prognosticators. The treatment effect of oil-based contrast was stronger in women with a BMI ≤30 kg/m2 [RR, 1.54; 95% CI, 1.23–1.92;
P = 0.002], and in women whose partner had a semen volume >3 ml [RR, 1.77; 95% CI, 1.28–2.46; P = 0.02]. Also, in women who smoked,
the treatment effect of flushing with oil was stronger, but this interaction did not reach statistical significance (P = 0.066). We found no positive
effect of oil-based contrast in obese women. We found similar but weaker associations for live birth, which was probably due to lower number
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LIMITATIONS, REASONS FOR CAUTION: The RCT was restricted to infertile ovulatory women younger than 39 years of age without
endocrinological disorders and at low risk for tubal pathology. Our results should not be generalized to infertile women who do not share
these features.
WIDER IMPLICATIONS OF THE FINDINGS: All infertile, ovulatory women younger than 39 years with a low risk for tubal pathology
will benefit from an HSG with oil-based contrast; therefore, this should be offered to them after fertility work-up.
STUDY FUNDING/COMPETING INTEREST(S): The original H2Oil RCT was an investigator-initiated study that was funded by the two
academic institutions (AMC and VUmc) of the Amsterdam UMC. The study displayed in this paper was funded by an unconditional research
grant from Guerbet. B.W.M. is supported by an NHMRC Practitioner Fellowship (GNT1082548). K.D. reports consultancy for Guerbet, during
the conduct of the study, and also reports research grants from Guerbet. C.B.L. reports grants from Guerbet, during the conduct of the study,
and grants from Ferring, grants from Merck, and personal fees from Ferring, outside the submitted work. P.H. reports grants from Guerbet,
during the conduct of the study, and grants from Ferring and Merck, outside the submitted work. V.M. reports receiving travel and speakers
fee as well as research grants from Guerbet. B.W.M. reports consultancy for ObsEva, Merck, Merck KGaA, and Guerbet, and research grants
from Guerbet and Merck. The other authors have no conflict of interest to declare.
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WHAT DOES THIS MEAN FOR PATIENTS?
Hysterosalpingography is an X-ray procedure (sometimes called ‘tubal flushing’) that uses contrast material to show whether the fallopian
tubes are blocked and is a common part of a work-up for women having difficulty becoming pregnant. The two contrast materials used are
either water-based or oil-based. We recently showed that in infertile women undergoing hysterosalpingography, flushing with oil-based contrast
material results in more pregnancies than flushing with water-based contrast material.
In this study, we studied the number of pregnancies achieved following the water- and oil-based procedures and, using computer models,
tried to identify a group of women who would benefit more from one contrast material than the other. Such information is helpful in the new
approach of personalized medicine, in which a patient’s baseline information (or ‘markers’ such as age, type of infertility, smoking status) is used
for personalized disease management and treatment selection. The results here are based on information obtained in an earlier clinical trial
involving 1,119 women.
We found that the 6-month cumulative ongoing pregnancy rates following this X-ray examination were higher with oil-based (40%) than with
water-based (29%) contrast. The effect of oil-based contrast was stronger in lean (not overweight/obese) women, in women whose partner
had a higher semen volume, and possibly in smokers. However, even in women with a partner with a lower semen volume, the flushing with oil
was still more beneficial than water. We were, however, unable to identify any one particular group of women who would benefit more from
flushing with one contrast material than the other.
Therefore, our results show that all infertile, ovulatory women less than 39 years of age with a low risk of fallopian tube disorders benefit
from tubal flushing with the oil-based contrast.
Introduction
While hysterosalpingography (HSG) traditionally has been used as a
diagnostic test, it has been suggested for more than half a century
that flushing with oil-based contrast has a direct therapeutic effect
(Weir and Weir, 1951). In order to solve the debate on the use
of oil- or water-based contrast for HSG, our group conducted a
large nationwide multicenter randomized controlled trial (RCT), the
H2Oil study, in which 1,119 infertile women participated (Dreyer et al.,
2017). In this trial, significantly more women became pregnant after an
HSG with oil-based contrast compared to an HSG with water-based
contrast within 6 months after randomization (39.7% versus 29.1%;
relative risk (RR), 1.37; 95% confidence interval (CI), 1.16–1.61).
An RCT is considered to be the cornerstone of the evaluation of
therapeutic interventions in evidence-based medicine. Generally, the
main goal of an RCT is to make inferences about an overall treatment





































trial result does not imply that all future patients would benefit from
the new treatment and also a negative study does not mean that
all patients should be treated by the standard therapy (Pencina and
Peterson, 2016). Awareness of this has resulted in a new approach
of research into the field of precision or personalized medicine, in
which the patient’s baseline information is utilized for personalized
disease management and treatment selection. Based on the extensive
collection of the patient’s baseline information from a clinical trial, it
would be valuable to utilize such information to make inferences about
the individual-level treatment efficacy (Tajik and Bossuyt, 2011). Since
we did not perform subgroup analysis, an important clinical query
remains whether this result is generalizable to all individual infertile
women.
Therefore, the objective of this study was two-fold. First, we eval-
uated the potential of individual baseline characteristics of infertile
couples for identifying markers that indicate treatment benefit. Second,
we aimed to combine the selected promising markers to form a
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multivariable model, which may provide guidance in utilizing oil-based
or water-based HSG in infertile couples.
Materials and Methods
Study design and patients
This is a secondary analysis of the H2Oil trial (NTR 3270), an RCT
comparing the use of oil-based contrast and water-based contrast in
infertile women undergoing HSG (Dreyer et al., 2017). In summary,
women were eligible for the study if they were between 18 and
39 years of age, had spontaneous menstrual cycles, had been trying
to conceive for at least 1 year, and had a low risk for tubal pathology
without a severe male factor (total motile sperm count after sperm
wash of less than 3 million sperm per milliliter).
Women were randomly assigned in a 1:1 ratio to the use of oil-based
contrast medium (Lipiodol Ultra-Fluid, Guerbet, Netherlands B.V.) (the
oil group) or water-based contrast medium (Telebrix Hystero, Guer-
bet) (the water group) during HSG. HSG was performed according to
local protocols, using plastic syringes.
Depending on the result of the HSG, couples were counselled for
expectant management (in case of a good prognosis for natural con-
ception, according to the prognostic model of Hunault et al. predicting
the likelihood for a natural conception within 12 months after HSG
(Hunault et al., 2005)) or had IUI (in case of a prognosis of <30% for
natural conception, according to the prognostic model of Hunault et al.
predicting the likelihood for a natural conception within 12 months after
HSG (Hunault et al., 2005)). In case of bilateral tubal blockage, women
were advised to undergo IVF-embryo transfer.
The primary outcome was ongoing pregnancy, defined as a fetal
heartbeat on ultrasound after 12 weeks of gestation, counting from
the first day of the last menstrual cycle prior to the pregnancy within
6 months after randomization. In this study, we considered live birth
as a secondary outcome. Live birth was defined as the birth of at least
one living child ≥24 weeks of gestation.
Statistical analysis
We predefined the following baseline characteristics as potential treat-
ment selection markers: female age at randomization, body mass index
(BMI), type of infertility (primary or secondary infertility), duration of
infertility at randomization, female ethnicity, smoking status, appen-
dectomy in the past, other abdominal surgery, cervical surgery in the
past (previous large loop excision of the transformation zone (LLETZ)
or conization of the cervix), semen volume (ml), semen concentra-
tion, semen motility (percentage), volume × concentration × motility
sperm (VCM), Hunault score (Hunault et al., 2005). We also devel-
oped a multivariable logistic regression model to predict unilateral tubal
occlusion and used the predicted risk as a separate marker in the
analyses. The details of developing this marker are summarized in the
Supplementary Data.
The outcome of interest was 6-month ongoing pregnancy, the
primary outcome of the H2Oil trial. We used data of H2Oil trial
participants and evaluated the potential of each marker for treat-
ment selection, separately. We started with univariable analysis and
developed separate linear regression models to predict the outcome































































































































contrast medium for HSG), and marker-by-treatment interaction term.
We considered markers that showed an interaction with treatment
with a P-value for interaction of less than 0.10 as markers promising
treatment benefit (Bensdorp et al., 2017, Steyerberg et al., 1999). We
selected these markers for the development of multivariable treatment
selection model. We used logistic regression for the development
of the treatment selection model and included all the selected vari-
ables and their interaction terms with treatment in the model. To
correct for potential overfitting in the multivariable model building,
we calculated and applied a shrinkage factor using a heuristic formula
(Steyerberg, 2009). We repeated the univariable analysis for the sec-
ondary outcome live birth.
To evaluate the performance of the multivariable model for treat-
ment selection, we used the model to calculate the chance of ongoing
pregnancy at 6 months after the use of water-based contrast medium
during HSG for each woman that had participated in the H2Oil trial.
We then used the model to calculate, for the same woman, the
chance of ongoing pregnancy at 6 months after the use of oil-based
contrast medium during HSG. We then subtracted the chance of
ongoing pregnancy after the use of water-based contrast medium from
the chance of ongoing pregnancy after the use of oil-based contrast
medium, in order to produce a chance difference. This estimate can be
regarded as an individual estimate of the treatment effect of oil-based
contrast medium compared to water-based contrast medium in the
individual woman.
We first studied the distribution of the calculated absolute chance
difference in the trial participants. We then assessed calibration
of the calculated absolute chance difference by comparing the
average calculated chance difference with the observed difference
in proportions of participants with 6 months ongoing pregnancy, in
groups defined by the deciles of the distribution of absolute chance
differences.
We assumed that any increase in chance of ongoing pregnancy as
a result of the use of oil-based contrast medium during HSG would
justify its use. Based on this assumption, we classified women into
those benefiting from oil-based contrast medium (a positive absolute
chance difference) and those not benefiting (a negative or zero absolute
chance difference). We then calculated the average chance difference
in the group predicted to benefit from oil-based contrast medium, and
the average chance difference in the group predicted not to benefit
from water-based contrast medium, separately. We then estimated the
hypothetical chance of ongoing pregnancy in the H2Oil study group if
the multivariable model was used to guide the choice between both
contrast media. This estimate can be interpreted as the population
benefit of using the model to guide the choice of a contrast medium (oil
or water), in terms of the expected increase in the chance of ongoing
pregnancy at 6 months after randomization. We obtained 95% CI for
each parameter using bootstrap resampling. We also tested whether a
strategy of using the model to choose a contrast medium would result
in a higher chance of ongoing pregnancy than the strategy of using oil-
contrast medium in all women.
All analyses of this study were exploratory and performed
based on the intention-to-treat analysis. We used R for Windows
(Version 3.0.1; R Foundation for Statistical Computing, Vienna,
Austria). Multiple imputation was performed by package ‘mice’ and
evaluation of model performance for treatment selection by package
‘TreatmentSelection’.
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Figure 1 Trial profile of the original randomized controlled trial (H2Oil). The figure presents the trial screening, randomization, and
follow-up of the in the original randomized controlled trial (H2Oil).
Results
We studied 1,108 women from the H2Oil trial, of whom 554 were
allocated to the use of oil-based contrast medium and 554 to water-
based contrast medium at HSG (Fig. 1). Baseline characteristics in
the two groups were comparable (Table I). The 6-month ongoing
pregnancy rates in the overall population were 39.7% after use of oil-
based contrast medium versus 29.1% after use of water-based contrast




















seen in IUI or IVF treatments within 6 months following HSG between
the two groups.
The associations between all investigated markers and the chances
of an ongoing pregnancy are shown in Table II. Among the stud-
ied baseline characteristics, BMI (P for interaction = 0.002) and
semen volume (P for interaction = 0.02) were statistically significant
prognosticators (Table III, Supplementary Figs S1 and S2). In the
oil-group, a BMI ≤30 kg/m2 was significantly associated with
higher chances of having an ongoing pregnancy. In the water
Can we personalize tubal flushing with oil? 5






Median age at randomization (years) (IQR∗) 32.8 (30.1–35.7) 33.0 (29.9–35.7)
Age 18 to 35 years (%) 379/553 (68.5) 382/552 (69.2)
Age ≥35 years (%) 174/553 (31.5) 170/552 (30.8)
Median BMI (kg/m2) (IQR∗) 23.0 (20.8–26.4) 22.8 (20.8–25.5)
BMI >30.0 kg/m2 (%) 61/509 (12.0) 43/499 (8.6)
Median duration of infertility (months) (IQR∗) 19.8 (16.0–26.3) 19.6 (15.4–27.4)
Ethnicityb
Caucasian (%) 409/554 (73.8) 415/554 (74.9)
Non-Caucasian (%) 57/554 (10.3) 61/554 (11.0)
Unknown (%) 88/554 (15.9) 78/554 (14.1)
Smoking c (%) 77/554 (13.9) 95/554 (17.1)
Previous large loop excision of the transformation
zone or conization of the cervix (%)
22/554 (4.0) 25/554 (4.5)
Previous tubal surgery (%) 2/554 (0.4) 0/554 (0.0)
Previous intestinal surgery (%) 33/554 (6.0) 37/554 (6.7)
Primary infertility (%) 373/554 (67.3) 374/554 (67.5)
Median total motile sperm count (IQR∗) 55.0 (19.0–126.9) 54.7 (21.7–111.1)
Median semen volume (ml) (IQR∗) 3.0 (2.1–4.3) 3.0 (2.2–4.0)
Median semen concentration (IQR∗) 44.0 (21.0–78.0) 42.0 (19.0–77.0)
Median semen motility (%) (IQR∗) 48.0 (33.3–59.0) 47.5 (35.0–60.0)
Based on baseline table published in Dreyer et al. (2017).
∗IQR: Interquartile range
group, more participants with a BMI >30 kg/m2 became pregnant,
although this difference was not statistically significant. In the oil
group, women whose partner had a semen volume > 3 ml were
significantly associated with higher chances of having an ongoing
pregnancy. Also in the oil group, women who smoked showed
higher chances of having an ongoing pregnancy, although this effect
was not statistically significant (P for interaction = 0.066; Table III,
Supplementary Fig. S3).
The multivariable model to predict unilateral tubal occlusion (which
consisted of duration of infertility, semen volume, semen concen-
tration, VCM, cervical surgery in the past (LLETZ or conization of
the cervix), and Hunault score) did not show any potential to be
a treatment selection marker for the chance of ongoing pregnancy
(P for interaction = 0.742). The interaction among female age (>35
versus ≤35 years), previous pregnancy, and the contrast medium
on ongoing pregnancy was not statistically significant (P for interac-
tion = 0.38).
The live birth rates in the overall population were 38.8% (214 out
of 552) after use of oil-based contrast medium versus 28.1% (155
out of 552) after use of water-based contrast medium (RR, 1.38;
95% CI, 1.17–1.64; P < 0.001). No differences were seen in IUI
or IVF treatments within 6 months following HSG between the oil
and water groups. The associations between all investigated markers
and the chance of a live birth are shown in Table IV. Among the
studied baseline characteristics, BMI (P for interaction = 0.004) and

























































prognosticators for a live birth (Table IV). Also, in the oil group, women
who smoked showed higher chances of having a live birth, although
this effect was not statistically significant (P for interaction = 0.068;
Table IV). The results of marker-by-treatment interactions on live
birth show similar but weaker associations compared to ongoing
pregnancy, probably due to lower number of events. We, therefore,
did not proceed to develop a multivariable model for this secondary
outcome.
Developing and performance of the
multivariable model
The multivariable model, including the three variables and their inter-
action with treatment, is presented in Table V. Figure 2 depicts the
distribution of the calculated differences in the chance of ongoing
pregnancy following oil- versus water-based contrast in the H2Oil trial
participants. Overall, 694 women had a positive chance difference and
were considered to benefit from oil-based contrast (87%; 95% CI, 73%
to 98%).
Calibration of the calculated risk differences is shown in Fig. 3. This
graph illustrates that the models is relatively well calibrated for both
positive and negative absolute chance differences.
In women for whom the multivariable model predicts a benefit from
oil-based contrast medium, the average increase in chance of ongoing
pregnancy by use of oil-based contrast medium was 13% (95% CI, 8%
to 18%). For those predicted to benefit from a water-based contrast
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Table III The association between most significant prognosticators and the chances of an ongoing pregnancy.





≤ 30 195/448 (43.5) 129/456 (28.3) 1.54 (1.23–1.92) 0.002
> 30 14/61 (23.0) 17/43 (39.5) 0.58 (0.28–1.18)
Semen volume (ml)
≤ 3 114/284 (40.1) 91/262 (34.7) 1.16 (0.88–1.52) 0.022
>3 101/252 (40.1) 56/248 (22.6) 1.77 (1.28–2.46)
Current smoker
No 177/441 (40.1) 133/433 (30.7) 1.31 (1.04–1.64) 0.066
Yes 33/77 (42.9) 19/95 (20.0) 2.14 (1.22–3.77)
medium, the average increase in chance of ongoing pregnancy by use
of water-based contrast medium was 7% (95% CI, 3% to 11%). We
estimate that by application of a model-based choice of contrast, the
chance of ongoing pregnancy could increase from 40% to 40.9% (0.9%;
95% CI, 0.1% to 2.7%; P-value <0.001).
Discussion
In this secondary analysis of a large RCT, we evaluated whether
there is a differential effect of potential treatment selection mark-
ers on the chance of an ongoing pregnancy and live birth after an
HSG with oil-based contrast medium compared to an HSG with
water-based contrast medium. In ovulatory infertile women, HSG
with oil-based contrast medium results in significantly higher 6-month
ongoing pregnancy and live birth rates as compared to HSG with
water-based contrast medium. We found the treatment effect to be
largely independent of characteristics of the couple, although lean
women, women whose partner has a large semen volume, and pos-
sibly smokers might benefit more from the use of oil-based con-
trast. We built a multivariate model using these three markers and
we found that by application of this model, a small but statistically
significant increase in the chance of ongoing pregnancy could be
expected.
Strengths and limitations
Our analysis was based on data from an RCT and therefore none of the
baseline characteristics had affected the allocation of treatment. This
gave us the opportunity to study the association between treatment
selection markers and oil-based or water-based contrast medium
without the risk of selection bias. The analysis presented here is the first
to look at the potential effects of baseline predictive factors in infertile
couples on ongoing pregnancy and live birth rates after an HSG with
oil-based contrast medium compared to water-based contrast medium
during fertility work-up.
Although the multivariate model is calibrated and shows statisti-

















































































population-level ongoing pregnancy rate by application of the model-
based strategy is relatively small (an increase from 39.9% to 40.9%),
because only a small group of women would be selected for water-
based contrast. Therefore, the clinical relevance of the model and its
effect as a treatment selection tool is questionable.
Clinical implications
An important step in the evaluation of the performance of any treat-
ment selection marker is asking for a threshold for the treatment effect,
and whether the treatment effect exceeds a pre-specified thresh-
old (Bossuyt and Parvin, 2015). However, indicating a pre-specified
threshold is not typically done in randomized trials. In this study, we
assumed any increase in chance of ongoing pregnancy as a result
of using oil-based contrast medium would justify its use, but one
can argue that the threshold does not have to be zero for all or
even the same for individual trial participants. On the other hand,
one could also argue that the threshold is dependent on the costs
of an additional ongoing pregnancy. We showed in our economic
evaluation of the H2Oil trial (with a difference of 10.7% in ongo-
ing pregnancy rate) that when one accepts to pay $US 8,000 for
an additional ongoing pregnancy, HSG with oil-based contrast is a
cost-effective strategy compared to HSG with water-based contrast
(van Rijswijk et al., 2018a).
The underlying mechanism of the fertility-enhancing effect of flushing
with oil-based contrast medium is unknown. Various studies suggest
an immunobiological effect of the oil on the endometrium and the
peritoneum (Izumi et al., 2017, Johnson, 2005, Johnson, 2014, Mikulska
et al., 1994, Sawatari et al., 1993, Yun and Lee, 2004) or enhancement
of the tubal ciliary activity (Soules and Spadoni, 1982). Another poten-
tial explanation is a mechanical effect, during tubal patency testing with
oil-based contrast medium debris or mucus plugs flushes out of the
fallopian tubes (Gillespie, 1965). Our study group recently performed
a subgroup analysis of the H2Oil study on pain scores and ongoing
pregnancies. There was a significant interaction between pain scores
and ongoing pregnancy; in women with a high pain score during HSG,
the ongoing pregnancy rate significantly increased in the oil group, while
in women with a low pain score, no effect of the oil-based contrast
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Table V Multivariable model for the prediction of chance
of ongoing pregnancy.




BMI 1.02 (0.98–1.06) 0.021
Semen volume 0.90 (0.80–1.01) −0.107
Smoking 0.65 (0.39–1.10) −0.424
Oil versus water contrast HSG 3.78 (0.89–16.07) 1.329
Interaction terms
BMI × oil versus water contrast
HSG
0.94 (0.89–0.99) −0.061
Smoking × oil versus water contrast
HSG
1.82 (0.90–3.69) 0.600
Semen volume × oil versus water
contrast HSG
1.17 (1.00–1.37) 0.158
∗∗∗Shrunken with an average shrinkage factor of 0.986
HSG: hysterosalpingography
medium was seen (van Welie et al., 2018). This points at a possible
mechanical effect of oil-based contrast medium.
One explanation for the fact that women whose partner had a semen
volume of more than 3 ml were significantly associated with higher
chances of having an ongoing pregnancy (and a live birth) might be that
in couples with better sperm quality, the probability of a hidden tubal
problem is higher, and therefore flushing with oil-based contrast is more
effective. However, this was not observed for other sperm parameters.
Similarly, women with obesity might benefit less from tubal flushing with
oil-based contrast, since obesity is associated with decreased fecundity,
even in ovulatory women (van der Steeg et al., 2008). A similar impact
could be anticipated in older women, but the age limit of 38 years
might have prevented us from observing this phenomenon. Although
the interaction between treatment effect of oil-based contrast and
smoking was not statistically significant, smokers have tubal damage and
dysfunction induced by nicotine and other smoking-related chemicals,
which may be related to more tubal debris and mucus plugs caused by
abnormal ciliogenesis associated with smoking (Nio-Kobayashi et al.,
2016, Shao et al., 2012).
We have presented the 3–5 year follow-up data for the RCT at the
ESHRE conference, with 3-year cumulative live birth rates of 83.2% and
80.7% in the oil group and the water group, respectively (van Rijswijk
et al., 2018b). This long-term follow-up also incorporates the results
of IVF treatments (25% of the women in the oil-group and 31% of the
women in the water group had IVF), and this might mask the treatment
effect of oil and water contrast on pregnancies that occur though the
fallopian tubes. We therefore decided not to repeat the marker analysis
for the long-term follow-up.
Conclusion
In ovulatory infertile women, HSG with oil-based contrast medium
results in significantly higher 6-month ongoing pregnancy and live birth





























































































































Figure 2 Distribution of the estimated difference in chance
of ongoing pregnancy. The figure shows the distribution of the
predicted difference in chance of an ongoing pregnancy following oil-
versus water-based contrast in the H2Oil trial participants.
presence of a treatment effect is not related to characteristics of
the couple, although lean women, women whose partner has a large
semen volume, and possibly smokers might benefit more from the
use of oil-based contrast. All infertile, ovulatory women younger than
39 years of age with a low risk for tubal pathology will benefit from
an HSG with oil-based contrast; therefore, this should be offered to
them.
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Supplementary data are available at Human Reproduction Open online.
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Figure 3 Calibration plot of the multi-marker benefit score. The figure represents the calibration of the multi-marker model. The X-axis
shows the observed chance of ongoing pregnancy and the Y-axis shows the predicted chance of ongoing pregnancy separately for women who received
oil-based contrast (solid circles) and those who received water-based contrast (triangles). The dotted line depicts full calibration.
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